Selecting the Best Proton Therapy Centres in India for Australian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 23-08-2026

Australia has been genuinely trying to build its own proton therapy capability, and it's worth understanding exactly where that stands before anything else in this guide. The Australian Bragg Centre for Proton Therapy and Research in Adelaide, a $500 million facility and the first of its kind in the Southern Hemisphere, completed construction in 2023. Installation of the proton therapy unit itself, however, has been delayed, and as of the most recent published update there is no confirmed date for when Australian patients will actually be able to walk in and be treated there. In the meantime, the established pathway for Australians needing proton therapy is the Commonwealth's Medical Treatment Overseas Program, which has funded access to this technology abroad precisely because no domestic alternative has existed. This guide is written for that group: patients whose radiation oncologist has confirmed proton therapy is the appropriate treatment, who are choosing where to have it, while Australia's own facility remains in delay. In 24 years of guiding international patients into Indian hospitals, I have found this to be one of the more genuinely narrow, well-defined groups in this entire series — proton therapy is not the right choice for most cancers, and a responsible radiation oncologist will tell you so directly.

Healing Journeys of Australian Patients

Australian Patients Share Their Experience

Key Takeaways

• The guide first explains Australia's current proton therapy situation. The Australian Bragg Centre in Adelaide has completed construction, but installation of the proton therapy unit has been delayed and there was no confirmed treatment opening date in the latest cited update. The guide therefore discusses overseas treatment for eligible Australian patients while this situation remains unresolved.
• The guide strongly emphasises that proton therapy is not appropriate for every cancer. Its potential value is particularly relevant in selected cases such as childhood brain or spinal tumours, skull-base or spinal-cord-adjacent tumours, certain ocular tumours and selected situations involving previous radiation exposure.
• Patients are advised to obtain a written, tumour-specific assessment from their Australian radiation oncologist before contacting an overseas centre. The guide considers a centre that recommends proton therapy without first assessing individual candidacy to be a significant warning sign.
• The team accounts for 55 out of 100 points, with honest assessment of whether proton therapy is appropriate receiving the highest weight of 16 points. Other major criteria include review of actual imaging, volume in the specific tumour type, paediatric experience where relevant and coordination with the Australian oncology team.
• The hospital accounts for 45 out of 100 points. Important factors include a genuinely operating proton facility, dedicated medical physics expertise, multidisciplinary tumour-board review, independently verifiable accreditation and a complete treatment record that the Australian oncologist can use.
• The guide identifies four warning signs: proton therapy recommended without a tumour-specific reason, pricing before imaging review, no named medical physicist and marketing claims suggesting proton therapy universally cures cancers that conventional radiation cannot. It also highlights MTOP funding, Australian oncology coordination, visa planning and follow-up arrangements.

Quick Facts

Treatment

Proton Beam Therapy

Country

India

Patients

Australian Patients

Main Focus

Precision Radiation Treatment

Key Indications

Selected Brain, Spinal, Skull-Base & Ocular Tumours

Special Consideration

Previous Radiation to the Same Area

Selection Criteria

10 Weighted Criteria

Team Weight

55 out of 100

Hospital Weight

45 out of 100

Key Specialist

Radiation Oncologist

Highest Criterion

Honest Proton Therapy Candidacy Assessment

Key Experience

Specific Tumour-Type Proton Therapy Volume

Medical Physics

Dedicated Proton Therapy Physics Team

Hospital Requirement

Genuine Operating Proton Facility

Team Approach

Multidisciplinary Tumour Board

Key Record

Full Treatment Plan & Total Dose

Funding Consideration

Medical Treatment Overseas Program

Warning Signs

Unjustified Recommendation or Early Pricing

Follow-Up

Australian Oncology Team

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Australian patients considering proton therapy in India, the guide recommends first confirming with an Australian radiation oncologist that proton therapy is genuinely appropriate for the tumour. Patients should provide their actual imaging and ask the Indian centre about experience with the same tumour type, paediatric expertise where relevant and the named medical physicist responsible for treatment planning. The centre should have an operating proton facility, dedicated proton medical physics, multidisciplinary review and verifiable accreditation. Patients should also explore Medical Treatment Overseas Program (MTOP) funding, coordinate with their Australian oncology team and return home with the complete treatment plan and total dose record.

Before you choose anyone: confirm proton therapy is actually the right treatment

Conventional radiotherapy, delivered by an experienced Australian oncologist, remains excellent and entirely appropriate for the great majority of cancers. Proton therapy's genuine advantage concentrates in specific situations: children with brain or spinal tumours, where growing tissue is especially sensitive to radiation beyond the intended target; tumours at the skull base or wrapped around the spinal cord, where critical structures sit millimetres from the target; certain ocular tumours, where preserving vision is a priority; and a second course of radiation to an area that has already been treated once.

Get a written, specific assessment from your Australian radiation oncologist on whether your tumour falls into this category before your first overseas conversation. This is worth being direct about: a centre that recommends proton therapy for every enquiry, rather than assessing candidacy specifically, is not one to trust.

Part one: judging the team

1. Honest assessment of whether proton therapy is right for you. This is the single heaviest criterion in this guide. Ask the treating radiation oncologist directly why proton therapy specifically, rather than conventional radiotherapy, is being recommended for your tumour.

2. The radiation oncologist reviews your actual imaging. Insist on this happening before any recommendation is made, not after a quote has already been discussed.

3. Volume in your specific tumour type. Ask how many cases similar to yours, in tumour type and location, the centre has treated with proton therapy specifically.

4. Paediatric-specific experience, where relevant. If the patient is a child, ask specifically about the team's experience treating children with proton therapy, including sedation or anaesthesia protocols for younger patients who cannot remain still for treatment.

5. Coordination with your Australian oncology team. Ask how the centre plans to communicate with your existing Australian oncologist throughout treatment, not just at the end.

Part two: judging the hospital

6. A genuinely operating proton facility, not a converted suite. Ask how long the centre has been treating patients with proton therapy and how many courses it delivers annually.

7. A dedicated medical physics team. Proton planning is a specialised discipline distinct from conventional radiation physics. Confirm this team's specific proton experience.

8. Multidisciplinary tumour board review. Ask whether your case will be reviewed by a genuine team before treatment is finalised.

9. Accreditation you can verify yourself. JCI is the international arm of the body accrediting hospitals across the United States; NABH is India's national equivalent, recognised by the same global standards authority.

10. A record your Australian oncologist can use. Before you leave you should hold the full treatment plan and total dose delivered, in writing.

What the quote should say, and what it usually omits

In 24 years I have found that disputes almost never concern the quoted price. They concern what the quote silently omitted.

Insist on a written, itemised figure that states the full course, including planning imaging. Understand what does not travel with you: standard Medicare arrangements do not cover treatment overseas outside MTOP funding, and standard travel insurance excludes planned treatment. Pay a deposit to secure the date, never the full balance in advance.

Four Signals that Should Make You Pause

1. Proton therapy recommended without a clear, tumour-specific rationale. It is not a universal upgrade over conventional radiotherapy, and a responsible team explains exactly why it's right for you.

2. A price quoted before your imaging has been reviewed. Nobody can price this treatment, or confirm candidacy, without seeing your specific scans.

3. No named medical physicist involved in your treatment plan. This role is central to the technology working safely and accurately.

4. Marketing language implying proton therapy cures cancers conventional radiation cannot. Legitimate centres describe a precision advantage in specific situations, not a categorically different outcome.

Australia-specific considerations most patients miss

Apply for Medical Treatment Overseas Program funding directly. Since Australia currently has no operating domestic proton facility, this is precisely the circumstance MTOP exists for. Ask your radiation oncologist to support the application with a clear clinical rationale.

Tell your Australian oncology team early, not after the fact. A team informed from the outset is better placed to coordinate your ongoing care.

Send the imaging, not just the report. A genuine candidacy assessment requires the actual scans.

Ask about the Bragg Centre's expected timeline directly. If your treatment isn't urgent, ask your oncologist whether waiting for Australia's own facility is realistic for your specific case, though this should not be assumed given the repeated delays to date.

Apply for both visas together. Australian passport holders are eligible for India's electronic medical visa, with an e-medical attendant visa for whoever travels with you.

Ask what happens if follow-up imaging shows the tumour hasn't responded as expected. Establish this plan before you travel.

The Questions, in the Order You Should Ask Them

A closing word

Proton therapy is a genuinely precise, well-established treatment for a specific, narrow group of tumours, and Australia's own facility remains delayed with no confirmed opening date. If your radiation oncologist has confirmed you're a candidate, apply for MTOP funding, confirm the team's genuine proton-specific experience, and ask directly why this technology, not conventional radiotherapy, is right for your tumour. If you have imaging or a treatment plan you would like reviewed, send it and I will look at it properly.

Frequently Asked Questions by Australians about Proton Therapy Centres in India

Is proton therapy suitable for every cancer?

No. The guide clearly states that proton therapy is appropriate only for a narrower group of cases where its precision may provide a meaningful advantage.

Which cases may particularly benefit from proton therapy?

The guide highlights selected childhood brain or spinal tumours, skull-base or spinal-cord-adjacent tumours, certain ocular tumours and some cases requiring another course of radiation to a previously treated area.

What should an Australian patient do before contacting an Indian centre?

The patient should obtain a written assessment from their Australian radiation oncologist confirming whether proton therapy is appropriate for the specific tumour.

What is the most important selection criterion?

The highest-weighted criterion is an honest assessment of whether proton therapy is actually right for the patient, receiving 16 out of 100 points.

Why should patients send actual imaging?

The guide recommends that the radiation oncologist review the patient's actual scans before making a recommendation or discussing a treatment quote.

What medical physics support should a centre have?

Patients should confirm that a dedicated medical physics team with specific proton experience is involved in patient-specific treatment planning. The guide also recommends asking for the named medical physicist.

What should patients ask about tumour-specific experience?

They should ask how many cases similar to theirs, considering tumour type and location, the centre has treated specifically with proton therapy.

What are the main warning signs?

The guide identifies an unexplained proton recommendation, pricing before imaging review, absence of a named medical physicist and claims that proton therapy universally cures cancers that conventional radiation cannot as reasons to pause.

Can Australian patients seek government funding?

The guide advises eligible patients to investigate the Medical Treatment Overseas Program (MTOP) and ask their Australian radiation oncologist to support the application with a clear clinical rationale.

What records should patients bring back to Australia?

Patients should return with the full treatment plan and total dose delivered in writing, so their Australian oncology team can continue appropriate follow-up.

Sources

• Australian Bragg Centre for Proton Therapy and Research, SAHMRI, project status updates — sahmri.org
• Australian Government Medical Treatment Overseas Program, eligibility criteria — health.gov.au
• National Medical Commission, recognised postgraduate medical qualifications in radiation oncology — nmc.org.in
• Joint Commission International, accreditation registers — jointcommissioninternational.org
• National Accreditation Board for Hospitals & Healthcare Providers, accreditation registers — nabh.co
• High Commission of India, e-Visa categories and eligibility — indianvisaonline.gov.in

Page Summary

This seven-page guide helps Australian patients evaluate proton therapy centres in India after confirming that proton therapy is appropriate for their specific tumour. It explains Australia's current Bragg Centre status and the interim overseas treatment pathway while the domestic facility remains delayed. The guide uses 10 weighted criteria, with 55 points for the team and 45 for the hospital. Key factors include honest treatment assessment, actual imaging review, tumour-specific experience, paediatric expertise, dedicated medical physics and multidisciplinary review.

Citation Block

Field	Information
Topic	Proton Therapy Centres
Treatment	Proton Beam Therapy
Country	India
Patients	Australian Patients
Main Focus	Precision Radiation Treatment
Key Indications	Brain, Spinal, Skull-Base & Ocular Tumours
Key Specialist	Radiation Oncologist
Selection Criteria	10 Weighted Criteria
Team Weight	55 out of 100
Hospital Weight	45 out of 100
Highest Criterion	Honest Candidacy Assessment
Key Experience	Specific Tumour-Type Proton Volume
Medical Physics	Dedicated Proton Physics Team
Hospital Requirement	Genuine Operating Proton Facility
Team Approach	Multidisciplinary Tumour Board
Key Record	Full Treatment Plan & Total Dose
Funding	Medical Treatment Overseas Program
Follow-Up	Australian Oncology Team